Aclidinium
- Generic Name
- Aclidinium
- Brand Names
- Bretaris Genuair, Duaklir, Duaklir Genuair, Eklira Genuair, Tudorza, Tudorza Genuair
- Drug Type
- Small Molecule
- Chemical Formula
- C26H30NO4S2
- CAS Number
- 727649-81-2
- Unique Ingredient Identifier
- K17VY42F6C
- Background
Aclidinium is an anticholinergic for the long-term management of chronic obstructive pulmonary disease (COPD). It has a much higher propensity to bind to muscarinic receptors than nicotinic receptors. FDA approved on July 24, 2012.
- Indication
用于治疗慢性支气管炎或肺气肿引起的急性支气管痉挛。
- Associated Conditions
- Chronic Obstructive Pulmonary Disease (COPD)
- Associated Therapies
- -
Evaluation of Long-Acting Muscarinic Antagonists in COPD
Phase 4
Completed
- Conditions
- Interventions
- First Posted Date
- 2014-01-17
- Last Posted Date
- 2019-04-12
- Lead Sponsor
- University of Dundee
- Target Recruit Count
- 15
- Registration Number
- NCT02039050
- Locations
- 🇬🇧
Asthma and Allergy Research Group, University of Dundee, Dundee, United Kingdom
A Dose-Range Finding Study of SUN-101 in Subjects With Moderate to Severe COPD
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2014-01-17
- Last Posted Date
- 2018-04-10
- Lead Sponsor
- Sunovion Respiratory Development Inc.
- Target Recruit Count
- 96
- Registration Number
- NCT02038829
- Locations
- 🇺🇸
Clinical Research of West Florida, Inc., Clearwater, Florida, United States
🇺🇸North Carolina Clinical Research, Raleigh, North Carolina, United States
🇺🇸American Health Research, Inc., Charlotte, North Carolina, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath